evidence-based statements of Strong, Moderate, or Conditional Recommendation, which can be supported by any body of evidence strength, were developed based on benefits and risks/burdens to patients
Prescribing information (Eli Lilly, 2025)
doi: 10.1016/S1474-4422(15)00141-6 51 ZhengMWangP
Each consultation covers full medical history, potential contraindications, and metabolic screening before any prescription is written
Overall, both classes are indifferently recommended by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) as first-line therapy in patients with T2DM and established ASCVD or multiple ASCVD risk factors to reduce the risk of major adverse cardiovascular events (MACE), such as myocardial infarction, stroke, and cardiovascular death [6, 7]
Smriti Choudhary, MD staff contact us Table of Contents: What are the benefits of Semaglutide GLP-1